Dihydrofolate reductase (DHFR) and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/IMP cyclohydrolase (PurH) play key roles in maintaining folate pools in cells, and are targets of antimicrobial and anticancer drugs. While the activities of bacterial DHFR and PurH on their classical substrates (DHF and 10-CHO-THF, respectively) are known, their activities and kinetic properties of utilisation of 10-CHO-DHF are unknown. We have determined the kinetic properties (k cat /K m ) of conversion of 10-CHO-DHF to 10-CHO-THF by DHFR, and to DHF by PurH. We show that DHFR utilises 10-CHO-DHF about one third as efficiently as it utilises DHF. The 10-CHO-DHF is also utilised (as a formyl group donor) by PurH albeit slightly less efficiently than 10-CHO-THF. The utilisation of 10-CHO-DHF by DHFR is~50 fold more efficient than its utilisation by PurH. A folate deficient Escherichia coli (DpabA) grows well when supplemented with adenine, glycine, thymine and methionine, the metabolites that arise from the one-carbon metabolic pathway. Notably, when the DpabA strain harboured a folate transporter, it grew in the presence of 10-CHO-DHF alone, suggesting that it (10-CHO-DHF) can enter onecarbon metabolic pathway to provide the required metabolites. Thus, our studies reveal that both DHFR and PurH could utilise 10-CHO-DHF for folate homeostasis in E. coli.
INTRODUCTION
The folate pathway is central to the synthesis of purine nucleotides, thymidylate, glycine and methionine (Fig. 1) . The enzymes catalysing inter-conversions of the pathway intermediates are highly conserved across the three domains of life [1] [2] [3] [4] [5] [6] [7] . Dihydrofolate reductase (DHFR) catalyses the reduction of 7, 8-dihydrofolate (DHF) to 5, 6, 7, 8-tetrahydrofolate (THF) by utilising NADPH as a cofactor [8] [9] [10] . Serine hydroxymethyltransferase (GlyA) catalyses the conversion of serine and THF to glycine and 5, 10-methylene-tetrahydrofolate (5, 10-CH 2 -THF) [11] . Methylenetetrahydrofolate dehydrogenase-cyclohydrolase (FolD), a bifunctional homodimeric protein carries out sequential steps of converting 5, 10-CH 2 -THF to 5, 10-methenyltetrahydrofolate (5, 10-CH + -THF) followed by the conversion of the later to 10-formyltetrahydrofolate (10-CHO-THF) by its dehydrogenase and cyclohydrolase activities, respectively [12, 13] . Availability of 10-CHO-THF is crucial for glycinamide ribonucleotide transformylase (PurN) and bifunctional enzyme PurH [aminoimidazole carboxamide ribonucleotide (AICAR) transformylase and IMP cyclohydrolase] in a de novo pathway of purine nucleotides biosynthesis in bacteria and eukaryotes. Availability of 10-CHO-THF is also vital for formylation of the initiator tRNA (tRNA fMet ) in eubacteria and eukaryotic organelles [14] [15] [16] . PurH catalyses formylation of AICAR to 5-formyl-AICAR (FAICAR) using 10-CHO-THF as a formyl group donor. FAICAR is then cyclised to form IMP [17] .
DHFR plays a central role in the maintenance of cellular pools of folate species which are essential for cellular growth and proliferation. The enzyme is a well known target of methotrexate and trimethoprim (TMP) for inhibiting growth of cancer cells and bacteria. TMP binds to bacterial DHFRs~10 5 fold more tightly than to the vertebrate DHFRs. Thus, it is an important antibacterial agent [18] . DHFRs have been extensively studied from many organisms [18] and their kinetic characterisations have also been carried out using DHF, its well known substrate [19] [20] [21] . The 10-formyl-dihydrofolate (10-CHO-DHF) is readily utilised in vitro by DHFR of human leukemic cell extract, and is also a bioactive compound [22] . However, the kinetic properties of 10-CHO-DHF utilisation by DHFR, and its bioactivity in bacteria have not been studied.
PurH has been studied extensively as a target of specific inhibitors for the development of anticancer therapeutics [23] . The enzymes reported from human and chicken catalyse both 10-CHO-THF and 10-CHO-DHF [17, 24] . Further, it was hypothesised that 10-CHO-DHF was the in vivo substrate for mammalian PurH [25] . PurH proteins from bacterial and eukaryotic sources reveal several differences when analysed by multiple sequence alignment (Fig. S1 , available in the online version of this article) or by comparison of the three dimensional (3D) structure of human PurH (pdb: 1PL0) with the modelled structure of E. coli PurH (EcoPurH) (Fig. S2) . However, bacterial PurH proteins have not been studied for their preferences for 10-CHO-DHF and 10-CHO-THF.
In this study, using E. coli as a bacterial model, we carried out in vitro and in vivo studies of E. coli DHFR (EcoDHFR) and EcoPurH to investigate their activities on 10-CHO-DHF. We show that for maintaining folate homeostasis, the folate pathway in E. coli involves recycling of DHF, 10-CHO-DHF and THF.
METHODS
Chemicals, plasmids, DNA oligomers, E. coli strains and their growth The 7, 8-dihydrofolic acid (DHF), (6S)-5-formyl-5, 6, 7, 8-tetrahydrofolic acid, calcium salt (5-CHO-THF) were from Schircks Laboratories (Jona, Switzerland). Stock solution of 5, 10-CH + -THF was prepared from 5-CHO-THF in acidic solution (0.1 M HCl and 0.1 M b-mercaptoethanol) with minimal light exposure. We prepared 10-CHO-THF from 5, 10-CH + -THF in 50 mM Tris-Cl (pH 7.5), 0.1 M b-mercaptoethanol under N 2 -sparged conditions on ice. The 10-CHO-DHF was prepared from 10-CHO-THF following air oxidation as reported [26] . The concentrations of DHF, 5, 10-CH + -THF, 10-CHO-DHF, AICAR (Sigma) and NADPH Cloning and purification of DHFR, PurH, FolD All plasmid constructs were made using standard genetic engineering techniques. Dihydrofolate reductase (folA) from E. coli was PCR amplified using pBAD-pNTR-FP and pBAD-pNTR-RP primers, digested with SfiI and ligated to pBAD-SfiI (Amp R ) at the same sites to generate pBAD-SfiIfolA (p-folA). E. coli folD was cloned in NcoI and BglII sites of pQE60 to generate p-folD (Amp R ) [28] . The purH from E. coli was PCR amplified using purH-F and purH-R primers, digested with NdeI and XhoI and ligated to pET28b at the same sites to generate pET28b-purH (ppurH). All constructs were verified by DNA sequencing. For purification of DHFR and PurH, a single colony of Rosetta (DE3) pLysS harbouring either p-folA or p-purH was inoculated into LB medium containing desired antibiotics and grown overnight. Fresh LB (900 ml) was inoculated with 1 % of the overnight culture and grown at 25 C (37 C for DHFR purification) until it reached exponential phase. The strain harbouring p-folA and p-purH were induced by arabinose (0.1 %) and isopropyl b-D-1-thiogalactopyranoside (IPTG, 0.5 mM), respectively and kept for further growth till saturation. The remaining strategy for purification of DHFR and PurH was same as used for purification of EcoFolD [28] . All proteins were purified to near homogeneity (as assessed by SDS-PAGE). The purified DHFR, PurH and FolD proteins were dialysed against 50 mM Tris-Cl (pH 7.6), 10 mM b-mercaptoethanol, 50 % glycerol (v/v) and KCl (50 mM for PurH only) and stored at À20 C.
Growth curves E. coli (3-4 biological replicates) were grown in 2 ml LB at 37 C with or without desired antibiotic(s) as overnight cultures. The cultures were diluted (10 3 ) in M9 minimal medium and 200 µl of these diluted cultures were taken into the wells of a honeycomb plate. The plate was placed in automated Bioscreen C growth reader (Oy Growth). The culture growth was measured at OD 600 at 1 h intervals. The graphs for growth analysis were prepared using GraphPad Prism in which mean values with standard deviation (SD) were plotted against time.
Enzyme assays and kinetics
His-tagged versions of DHFR, PurH and FolD from E. coli were purified using Ni-NTA columns, and used in the assays. DHFR activity was measured by a spectrophotometric method as done previously [27] . Briefly, DHFR activity was measured by decreases in the absorbance at 340 nm for 30 s in a buffer consisting of 50 mM Tris-Cl (pH 7.5) and 10 mM b-mercaptoethanol at room temperature. The kinetic constants of DHFR for its activity were determined for DHF, 10-CHO-DHF and NADPH. In one set of reactions, concentrations of DHF (1-55 µM) or 10-CHO-DHF (0.2-60 µM) were varied, keeping NADPH (60 µM) and DHFR (67.5 ng) concentrations constant in 500 µl volume. 
Validation of folate species by HPLC and HPLCcoupled electrochemical detector
Folates were analysed by HPLC-coupled electrochemical detector (HPLC-ECD) as described [32] . We followed a modified protocol for determination of folates by HPLC (Dionex, 3000 ultimate model). In brief, the folates in the reaction mixtures of either DHFR (0.4 µg) or PurH (1.6 µg) assays were acidified with 200 mM HCl and determined by HPLC and HPLC-ECD using 4.6Â150 mm C18 column (Dionex). DHF (100 µM), 10-CHO-DHF (100 µM) and 5, 10-CH + -THF (acidified 10-CHO-THF, 150 µM) were determined in HPLC on the basis of their retention times and absorption maxima at 282, 234 and 350 nm, respectively. These folates were also detected using a four-channel detector ECD (CoulArray Model 5600A, ESA) with potentials set at 0, 200, 400, and 600 mV. The mobile phase was 28 mM K 2 HPO 4 , pH set to 2. 
RESULTS
In vivo assessment of DHFR and PurH activities DHFR is an essential protein in E. coli. However, the folA gene (which encodes DHFR) could be deleted if it was accompanied with an inactivating mutation in thyA [33] . As also noted by the authors [33] , in the absence of deficient thyA activity, deficiency of DHFR (folA) will lead to increase in DHF and depletion of 5, 10-CH 2 -THF, which would adversely affect one-carbon metabolism (Fig. 1) . Thus, folA deletion is better tolerated along with an inactivating mutation in thyA. More importantly, to ensure in vivo activity of the plasmid expressed DHFR, we transformed the LH18 strain (NM522 thyADfolA :: kan) with p-folA plasmid, and checked the growth of the transformants in M9 minimal medium containing thymidine. We noted that LH18 strain harbouring an empty vector (lacking folA) showed only residual growth in M9 medium while the LH18/p-folA strain grew well (Fig. 2a) . The DpurH strain did not grow in M9 media but it grew when supplemented with adenine (Fig. 2b) or supported with p-purH (Fig. 2c) . These observations are consistent with the fact that both folA and purH are essential, and that their growth deficiency phenotypes (in un-supplemented M9 medium) are direct consequences of the gene deletions (and not due to any changes in their genomic loci). (DHFR), S3b (PurH) and S3c (FolD)]. The theoretical molecular weight of His-tagged DHFR is 19.7 kDa. However, the observed molecular weight of DHFR on SDS-PAGE was~22 kDa.
Purification of DHFR, PurH and FolD

Kinetic parameters of DHFR and PurH proteins
The kinetic constants of DHFR and PurH activities were determined ( 
Identification of the reaction products of DHFR and PurH by HPLC and HPLC-ECD
DHFR is known to convert DHF to THF [8, 27, 34] . And, PurH is known to convert 10-CHO-THF to THF [35] . However, as shown in Table 2 , both DHFR and PurH utilised even 10-CHO-DHF as substrate. To identify the reaction products, we made use of HPLC and HPLC-ECD. Based on the absorbance, retention time and reduction potential, it was observed that DHFR utilised 10-CHO-DHF and formed 10-CHO-THF (detected as 5, 10-CH + -THF in acidic conditions) (compare Fig. 3a vs c and 3b vs d) . Similarly, it was observed that PurH utilised 10-CHO-DHF and formed DHF (compare Fig. 4a vs c and 4b vs d) . The corresponding HPLC and HPLC-ECD profiles of buffer, standard 5, 10-CH + -THF (Fig. S6 ), DHF and 10-CHO-DHF (Fig. S7) are shown. Thus, the products (10-CHO-THF and DHF, respectively) formed in the DHFR and PurH assays could be identified as expected. The identity of the products formed in DHFR and PurH assays were further verified by coupled enzyme assays (Fig. S8) .
Engineering 10-CHO-DHF uptake complements for folate homeostasis The in vitro reactions showed that both DHFR and PurH utilised 10-CHO-DHF as substrate to form 10-CHO-THF and DHF, respectively. Thus, to investigate for 10-CHO-DHF utilisation in vivo, we decided to make use of a plasmid borne gene encoding a folate transporter (on p-FBT, Tet R ) to enable E. coli to obtain folates from the medium [35] . We chose E. coli DpabA strain which does not synthesise p-amino benzoic acid (pABA), an essential metabolite for the biosynthesis of folates (Fig. 1) . Expectedly, the DpabA strain did not grow in M9 media (Fig. 5a ). However, it grew when the medium was supplemented with 5-CHO-THF as control (Fig. 5b) . The strain showed growth even when the medium was supplemented with 10-CHO-DHF (Fig. 5c ). On the other hand, the LH18 strain (DfolA) harbouring p-FBT showed a poor growth in M9 medium. This growth was improved to some extent when supplemented with 5-CHO-THF but not with 10-CHO-DHF (Fig. 5d) . Similarly, on the M9 agar medium also, growth enhancement of LH18 was observed when the medium was supplemented with 5-CHO-THF but not when supplemented with 10-CHO-DHF (Fig. S9) .
Major physiological importance of folate pathway in DpabA strain
The folate pathway is central to the synthesis of purine nucleotides, thymidylate, glycine and methionine. The DpabA strain did not grow in M9 minimal media alone or in the medium supplemented with adenine or glycine (Figs 5a and 6a, b) . And, while the strain shows a barely detectable growth upon supplementation of the medium with thymine, growth was significant when supplemented Table 2 . Kinetic properties of DHFR and PurH with methionine (compare Fig. 6d with 6a, b and c) . The
DpabA strain grew as well as the wild-type strain when supplemented with adenine, glycine, thymine and methionine together (Fig. 6e) .
DISCUSSION
The folate metabolic pathway has been extensively explored [1] [2] [3] [4] [5] [6] [7] . Deletion of either DHFR or PurH from E. coli leads to growth defect in M9 media. The growth of the strains is rescued upon expression of the deleted genes, from a plasmid borne copy. The growth of DpurH strain was also rescued upon supplementation of the growth medium with adenine alone (Fig. 2b) . As adenine is known to be converted to purine nucleotides via the salvage pathway, the observation suggests a major role of EcoPurH in the biosynthesis of purine nucleotides. DHFR has been well characterised from many organisms using its primary substrate DHF [19] [20] [21] . In this study, we investigated for relative utilisation of DHF and 10-CHO-DHF by EcoDHFR. The catalytic efficiency of EcoDHFR (k cat /K m ) for DHF (249±93 min À1 µM À1 ) was only~2.7 fold higher than that for 10-CHO-DHF (92±27 min À1 µM À1 ) suggesting even the latter to be a good substrate for EcoDHFR. The catalytic efficiencies of EcoPurH were 2.6±1.2 and 1.7±1 min À1 µM À1 for 10-CHO-THF and 10-CHO-DHF, respectively (Table 2) . From in vitro experiments, we observed that DHFR converts 10-CHO-DHF to 10-CHO-THF, and PurH converts 10-CHO-DHF to DHF. These metabolites were identified by HPLC, HPLC coupled ECD and coupled enzymatic assays. From in vivo experiments, we observed that DpabA strain grew well in M9 media supplemented with 10-CHO-DHF. This suggests that 10-CHO-DHF is a bioactive metabolite that can enter in one-carbon metabolism and might be converted to other intermediary metabolites for growth. However, as assessed from the longer lag phases, the growth of the wild-type strain was somewhat delayed compared to that of the DpabA strain when supplemented with 5-CHO- THF (Fig. 5b) or 10-CHO-DHF (Fig. 5c) suggesting their toxicities to at least some extent, especially when the intermediates of the one-carbon metabolism are not altered (for example, in the wild-type strain). In this context, the GlyA enzyme in the folate pathway is known to be inhibited by 5-CHO-THF [36] . The rescue of growth defect in LH18 upon supplementation with 5-CHO-THF was seen both on the solid and liquid media (Figs 5d and S9 ). The DpabA strain was not observed to grow when the medium was supplemented with adenine alone (Fig. 6a) . However, the strain grew when the medium was supplemented with 10-CHO-DHF (Fig. 5c ). These observations suggest that 10-CHO-DHF is utilised to not only provide for the purines but also for other essential metabolites of one-carbon metabolism.
Interestingly, the growth of DpabA strain (Fig. 6 ) was rescued better by supplementation of the medium with methionine, a byproduct of one-carbon metabolic pathway (compared to that with glycine or thymine alone). Recently, the critical limitation of methionine and S-adenosyl methionine (SAM) was observed when the folate pathway of Mycobacterium tuberculosis was disrupted. And, the growth of M. tuberculuosis treated with antifolate drug (WR99210) was rescued when the media was supplemented with SAM alone or serine/methionine/glycine together [37] . Thus, it may be that besides the direct need of methionine in protein synthesis, it is crucially needed for the synthesis of SAM used as methyl donor for methylation of various biomolecules that play important physiological roles [38] . The growth of DpabA strain, when supplemented with adenine, glycine, thymine along with methionine, was as good as the wild-type strain (Fig. 6e) . The observations suggest that in the cell, 10-CHO-DHF is recycled to 10-CHO-THF which in turn generates other folates for the synthesis of purine nucleotides, glycine, thymine and methionine.
Taken together, our study supports a major role of DHFR in the synthesis of THF and 10-CHO-THF, and that of PurH in converting 10-CHO-THF and 10-CHO-DHF to THF and DHF, respectively. Thus, the utilisation of 10-CHO-DHF happens over two steps. Firstly, 10-CHO-DHF is converted to DHF in folate pathway and secondly, to 10-CHO-THF in one-carbon metabolic pathway (Fig. 1) . In conclusion, in vivo and in vitro characterisation of EcoDHFR and EcoPurH has allowed for a better . The DpabA strain did not grow even when supplemented with adenine (a) and glycine (b). However, the strain grew to some extent when supplemented with thymine (c) and still better when supplemented with methionine (d). The strain grew equivalent to the wild-type when supplemented with adenine, glycine, thymine and methionine altogether (e).
understanding of utilisation of 10-CHO-DHF in the synthesis of purine nucleotides, glycine, thymine and methionine.
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